WALL, NJ–(Mar 7, 2013) – BIO-key International, Inc. (OTCQB: BKYI), a global leader in fingerprint biometric identification solutions, advanced mobile credentialing and identity verification technologies, today announced that industry veteran, Jay Meier, has joined BIO-key and has been appointed Vice President Corporate Development.
“Jay brings a breadth of industry experience, both financial and technical, as well as a strong record of achievement, to our management team,” said Mike DePasquale, CEO, BIO-key. “We are thrilled to have him join our team. Jay’s energy, vision, creativity and leadership will help us continue to translate our leadership in biometric identification and authentication technologies into innovative world class products and solutions that are unparalleled in the market.”
Before joining BIO-key, Jay was Founder & Managing Partner of Sage Capital Advisors, which provides economic, capital market and strategic consulting services in the Security, Credentialing and Identity Management industries. Prior to that, Jay was SVP of Corporate Development for OTI-America, a leading provider of contactless smart card solutions. Previous to OTI, Jay worked as Finance Controller for a healthcare services firm and for many years as a Senior Research Analyst at various boutique investment banks. In June 2006, Jay published Secure Credentialing & Identification — Wall Street’s first and most comprehensive industry research overview of the Security, Biometrics, PKI, Smartcard, Credentialing and Identity Management industries. In 2003, he ranked in the 99th percentile of all securities analysts in North America. In 2004, he ranked in the 97th percentile. In 2005, the StarMine/Forbes Magazine Securities Analyst Ranking Survey named Jay “8th Best Stock Picker in North America.” Jay earned a BS-Economics from the University of Wisconsin-Madison in 1992.
As VP Corporate Development, Jay will be responsible for strategic and corporate development, primarily in the Healthcare markets. With his extensive financial analytical experience, he will also support C-level management regarding BIO-key’s operational execution, as well as manage BIO-key investor relations.
About BIO-key
BIO-key International, Inc., headquartered in Wall, New Jersey, develops and delivers 
advanced identification solutions to commercial and government enterprises, integrators, and custom application developers. BIO-key’s award winning, high performance, scalable, cost-effective and easy-to-deploy biometric finger identification technology accurately identifies and authenticates users of wireless and enterprise applications. Our solutions are used in local embedded OEM products as well as some of the world’s largest identification deployments to improve security, guarantee identity, and help reduce identity theft. BIO-key’s technology is offered directly or by market leading partners around the world. (http://www.bio-key.com)
BIO-key Safe Harbor Statement
Certain statements contained in this press release may be construed as “forward-looking statements” as defined in the Private Securities Litigation Reform Act of 1995 (the “Act”). The words “estimate,” “project,” “intends,” “expects,” “anticipates,” “believes” and similar expressions are intended to identify forward-looking statements. Such forward-looking statements are made based on management’s beliefs, as well as assumptions made by, and information currently available to, management pursuant to the “safe-harbor” provisions of the Act. These statements are subject to certain risks and uncertainties that may cause actual results to differ materially from those projected on the basis of these statements. These risks and uncertainties include, without limitation, our history of losses and limited revenue, our ability to develop new products and evolve existing ones, the impact on our business of the recent financial crisis in the global capital markets and negative global economic trends, our ability to attract and retain key personnel. For a more complete description of these and other risk factors that may affect the future performance of BIO-key International, Inc., see “Risk Factors” in the Company’s Annual Report on Form 10-K for the year ended December 31, 2011 and its other filings with the Securities and Exchange Commission. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date made. The Company also undertakes no obligation to disclose any revision to these forward-looking statements to reflect events or circumstances after the date made or to reflect the occurrence of unanticipated events.
Contacts: BIO-key International, Inc., Jay Meier, Jay.meier@bio-key.com, 651-789-6116
Follow Us